Physician profile
Thomas Alan Fox
NPI 1770583189
$1,273.11
in general payments reported to CMS, 2019-2025
16 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $52.54 · 2021: $150 · 2022: $183 · 2023: $377 · 2024: $199 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $314.00 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $221.52 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.18 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $91.07 | 2019-2021 | |
| Pfizer INC. | $77.45 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.81 | 2024-2025 | Trintellix |
| Novo Nordisk INC | $58.10 | 2022-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $56.61 | 2024-2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $53.56 | 2024 | |
| Abbott Laboratories | $46.75 | 2025 | Cardiomems |
| Abbvie INC. | $40.19 | 2022 | |
| Exact Sciences Corporation | $36.21 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $21.18 | 2024 | Veozah |
| Celgene Corporation | $16.43 | 2019 | |
| Dexcom, INC. | $14.00 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyera Pharmaceuticals, LLC | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.